Sotera Health stock gains 1.89 percent as Q2 growth supports outlook

Published on 10/05/2026 at 19:49 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Sotera Health stock posted Q2 revenue of USD 321.38 million, up 9.2 percent year over year, with adjusted EPS at USD 0.26. Eleven analysts set a Moderate Buy consensus.

SHC, US83601L1026, Illustration mit AI erstellt.

Sotera Health stock (ISIN US83601L1026) was trading at USD 18.57 on Nasdaq on October 5, 2026, up 1.89 percent from the prior close. The move follows a second-quarter update in which net revenue rose 9.2 percent year over year to USD 321.38 million, according to Sotera Health on August 6, 2026.

Q2 revenue beat the benchmark

The company reported Q2 2026 net income of USD 53.64 million, or USD 0.19 per diluted share, compared with USD 26.59 million and USD 0.09 per share in Q1 2026. That sequential increase gives the latest quarter a stronger earnings base than the first three months of the year.

MarketBeat reported on September 25, 2026, that adjusted EPS reached USD 0.26 against a USD 0.24 consensus, while revenue of USD 321.38 million exceeded the USD 309.70 million estimate.

Analysts see room above USD 18.57

The same MarketBeat report described a Moderate Buy consensus from 11 analysts, with eight Buy ratings and three Hold ratings. The average 12-month target was USD 21.50, placing the October 5 price 13.6 percent below that consensus target.

That assessment sits alongside a company outlook centered on operating leverage and cash generation. At the Wells Fargo Healthcare Conference on September 9, 2026, management discussed 2026 capital spending of USD 200 million to USD 225 million and guided to 20 to 25 basis points of additional EBITDA margin improvement, as reported by Investing.com.

Regulatory spending shapes the next phase

The conference discussion also tied the investment program to emission-control upgrades, Cobalt-60 development and new sterilization capacity. Management said the North Carolina X-ray facility was online and expected to contribute revenue in the second half of 2026, while capital spending should fall materially in 2027.

SHC trades below its 52-week high

SHC was trading at USD 18.57 on Nasdaq at 1:48 p.m. ET on October 5, 2026. The session range was USD 18.16 to USD 18.59, the 52-week range was USD 13.09 to USD 19.85, volume was 581,700 shares and market capitalization was USD 5.3 billion.